Civic Intelligence

Biopharmaceutical Applied Statistics Symposium Inc.

990EZ • Fiscal year 2012 • EIN 45-5190806

Jan 01, 2012 to Dec 31, 2012

Charlotte, NC
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

85th percentile

0.47x

Higher debt load relative to assets than 85% of similar nonprofits.

2012 filings • NTEE E • <$500k nonprofits • Source year 2012

Liabilities / Revenue

85th percentile

0.43x

Higher debt load relative to revenue than 85% of similar nonprofits.

2012 filings • NTEE E • <$500k nonprofits • Source year 2012

Net Margin

88th percentile

48%

Higher net margin than 88% of similar nonprofits.

2012 filings • NTEE E • <$500k nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2012

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2012

Assets

$42,535

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$19,986

No earlier filing loaded for comparison.

Revenue

$46,610

No earlier filing loaded for comparison.

Expenses

$24,061

No earlier filing loaded for comparison.

Net Income

$22,549

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2012: $42,535Liabilities 2012: $19,9862012Assets 2013: $54,097Liabilities 2013: $02013Assets 2014: $105,100Liabilities 2014: $02014Assets 2015: $139,089Liabilities 2015: $02015Assets 2016: $151,100Liabilities 2016: $02016Assets 2017: $166,067Liabilities 2017: $02017Assets 2018: $181,679Liabilities 2018: $02018Assets 2019: $198,204Net Assets 2019: $198,2042019Assets 2020: $207,875Net Assets 2020: $207,8752020Assets 2021: $220,321Liabilities 2021: $545Net Assets 2021: $219,7762021Assets 2022: $239,130Liabilities 2022: $1,063Net Assets 2022: $238,0672022Assets 2023: $240,570Liabilities 2023: $1,212Net Assets 2023: $239,3582023Assets 2024: $250,345Liabilities 2024: $1,288Net Assets 2024: $249,0572024

Highlighted filing

2012

Assets$42,535
Liabilities$19,986
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100K$50K$0Revenue 2012: $46,610Expenses 2012: $24,061Net Income 2012: $22,5492012Revenue 2013: $55,047Expenses 2013: $23,499Net Income 2013: $31,5482013Revenue 2014: $80,671Expenses 2014: $29,668Net Income 2014: $51,0032014Revenue 2015: $56,946Expenses 2015: $22,957Net Income 2015: $33,9892015Revenue 2016: $39,679Expenses 2016: $28,130Net Income 2016: $11,5492016Revenue 2017: $43,762Expenses 2017: $28,795Net Income 2017: $14,9672017Revenue 2018: $48,319Expenses 2018: $32,708Net Income 2018: $15,6112018Revenue 2019: $58,229Expenses 2019: $41,704Net Income 2019: $16,5252019Revenue 2020: $11,161Expenses 2020: $1,490Net Income 2020: $9,6712020Revenue 2021: $13,430Expenses 2021: $1,529Net Income 2021: $11,9012021Revenue 2022: $36,131Expenses 2022: $17,840Net Income 2022: $18,2912022Revenue 2023: $31,474Expenses 2023: $30,183Net Income 2023: $1,2912023Revenue 2024: $36,529Expenses 2024: $26,830Net Income 2024: $9,6992024

Highlighted filing

2012

Revenue$46,610
Expenses$24,061
Net Income$22,549
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

Educational symposium to raise funds to support graduate students in the field of biostatics.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings